These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34502483)

  • 1. Anti-Cancer Effects of Cyclic Peptide ALOS4 in a Human Melanoma Mouse Model.
    Levi B; Yacobovich S; Kirby M; Becker M; Agranyoni O; Redko B; Gellerman G; Pinhasov A; Koman I; Nesher E
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel synthetic cyclic integrin αvβ3 binding peptide ALOS4: Antitumor activity in mouse melanoma models.
    Yacobovich S; Tuchinsky L; Kirby M; Kardash T; Agranyoni O; Nesher E; Redko B; Gellerman G; Tobi D; Gurova K; Koman I; Ashur Fabian O; Pinhasov A
    Oncotarget; 2016 Sep; 7(39):63549-63560. PubMed ID: 27556860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma.
    Redko B; Tuchinsky H; Segal T; Tobi D; Luboshits G; Ashur-Fabian O; Pinhasov A; Gerlitz G; Gellerman G
    Oncotarget; 2017 Jan; 8(1):757-768. PubMed ID: 27768593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region.
    Amin M; Mansourian M; Koning GA; Badiee A; Jaafari MR; Ten Hagen TLM
    J Control Release; 2015 Dec; 220(Pt A):308-315. PubMed ID: 26526970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of TAX2 peptide as a new unpredicted anti-cancer agent.
    Jeanne A; Sick E; Devy J; Floquet N; Belloy N; Theret L; Boulagnon-Rombi C; Diebold MD; Dauchez M; Martiny L; Schneider C; Dedieu S
    Oncotarget; 2015 Jul; 6(20):17981-8000. PubMed ID: 26046793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel melanoma-targeting peptide screened by phage display exhibits antitumor activity.
    Matsuo AL; Tanaka AS; Juliano MA; Rodrigues EG; Travassos LR
    J Mol Med (Berl); 2010 Dec; 88(12):1255-64. PubMed ID: 20802991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo therapy of malignant melanoma by means of antagonists of alphav integrins.
    Mitjans F; Meyer T; Fittschen C; Goodman S; Jonczyk A; Marshall JF; Reyes G; Piulats J
    Int J Cancer; 2000 Sep; 87(5):716-23. PubMed ID: 10925366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of integrin β3 signals to reverse the stem-like phenotype and drug resistance in melanoma.
    Zhu X; Tao X; Lu W; Ding Y; Tang Y
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):615-624. PubMed ID: 30627776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.
    Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X
    Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Modulation of Interferon Response-Related Genes with IFN-Alpha/Lambda Inhibition.
    Sur D; Leonova K; Levi B; Markowitz SI; Cohen-Harazi R; Gitlin I; Gurova K; Gudkov A; Pinhasov A; Koman I; Nesher E
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
    Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
    J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity.
    Komatsu Y; Tomizaki KY; Tsukamoto M; Kato T; Nishino N; Sato S; Yamori T; Tsuruo T; Furumai R; Yoshida M; Horinouchi S; Hayashi H
    Cancer Res; 2001 Jun; 61(11):4459-66. PubMed ID: 11389076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α
    Zhong P; Meng H; Qiu J; Zhang J; Sun H; Cheng R; Zhong Z
    J Control Release; 2017 Aug; 259():176-186. PubMed ID: 27986551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The YSNSG cyclopeptide derived from tumstatin inhibits tumor angiogenesis by down-regulating endothelial cell migration.
    Thevenard J; Ramont L; Devy J; Brassart B; Dupont-Deshorgue A; Floquet N; Schneider L; Ouchani F; Terryn C; Maquart FX; Monboisse JC; Brassart-Pasco S
    Int J Cancer; 2010 Mar; 126(5):1055-66. PubMed ID: 19551865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo effects of a cyclic peptide with affinity for the alpha(nu)beta3 integrin in human melanoma cells.
    Allman R; Cowburn P; Mason M
    Eur J Cancer; 2000 Feb; 36(3):410-22. PubMed ID: 10708944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair.
    Christmann M; Diesler K; Majhen D; Steigerwald C; Berte N; Freund H; Stojanović N; Kaina B; Osmak M; Ambriović-Ristov A; Tomicic MT
    Oncotarget; 2017 Apr; 8(17):27754-27771. PubMed ID: 27487141
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Siitonen R; Peuhu E; Autio A; Liljenbäck H; Mattila E; Metsälä O; Käkelä M; Saanijoki T; Dijkgraaf I; Jalkanen S; Ivaska J; Roivainen A
    J Nucl Med; 2019 Oct; 60(10):1380-1387. PubMed ID: 30850498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformation-dependent binding of a Tetrastatin peptide to α
    Lambert E; Fuselier E; Ramont L; Brassart B; Dukic S; Oudart JB; Dupont-Deshorgue A; Sellier C; Machado C; Dauchez M; Monboisse JC; Maquart FX; Baud S; Brassart-Pasco S
    Sci Rep; 2018 Jun; 8(1):9837. PubMed ID: 29959360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matricellular TSP-1 as a target of interest for impeding melanoma spreading: towards a therapeutic use for TAX2 peptide.
    Jeanne A; Boulagnon-Rombi C; Devy J; Théret L; Fichel C; Bouland N; Diebold MD; Martiny L; Schneider C; Dedieu S
    Clin Exp Metastasis; 2016 Oct; 33(7):637-49. PubMed ID: 27349907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of histamine and clozapine in a mouse experimental model of human melanoma.
    Massari NA; Medina VA; Cricco GP; Martinel Lamas DJ; Sambuco L; Pagotto R; Ventura C; Ciraolo PJ; Pignataro O; Bergoc RM; Rivera ES
    J Dermatol Sci; 2013 Dec; 72(3):252-62. PubMed ID: 23999004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.